Tong, Le
Jiménez-Cortegana, Carlos
Tay, Apple H.M.
Wickström, Stina
Galluzzi, Lorenzo
Lundqvist, Andreas
Article History
Received: 19 August 2022
Revised: 10 September 2022
Accepted: 24 September 2022
First Online: 1 November 2022
Declarations
:
: Not applicable.
: LG is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. All other authors have no conflicts to declare.